Medical Care

Global Diabetes Devices and Drugs Market Research Report 2025

The global market for Diabetes Devices and Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Diabetes Devices and Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Devices and Drugs.
The Diabetes Devices and Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diabetes Devices and Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Devices and Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
BD
Johnson & Johnson
Abbott Laboratories
Novo Nordisk
Bristol-Myers Squibb
DexCom
Companion Medical
GlaxoSmithKline
Glenmark Pharmaceuticals
Novartis
Roche
Sanofi
MSD
Astrazeneca
Takeda
North China Pharmaceutical Group Corporation
Huadong Medicine
Dongbao Pharmaceutical
Hisun Pharmacy
KELUN
Ginwa
Tianan Pharmaceutical
Segment by Type
Diabetes Devices
Diabetes Drugs
Segment by Application
Diagnostic/Clinics
ICUs
Home Healthcare
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetes Devices and Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Devices and Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Diabetes Devices
1.2.3 Diabetes Drugs
1.3 Market by Application
1.3.1 Global Diabetes Devices and Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostic/Clinics
1.3.3 ICUs
1.3.4 Home Healthcare
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Devices and Drugs Market Perspective (2020-2031)
2.2 Global Diabetes Devices and Drugs Growth Trends by Region
2.2.1 Global Diabetes Devices and Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Diabetes Devices and Drugs Historic Market Size by Region (2020-2025)
2.2.3 Diabetes Devices and Drugs Forecasted Market Size by Region (2026-2031)
2.3 Diabetes Devices and Drugs Market Dynamics
2.3.1 Diabetes Devices and Drugs Industry Trends
2.3.2 Diabetes Devices and Drugs Market Drivers
2.3.3 Diabetes Devices and Drugs Market Challenges
2.3.4 Diabetes Devices and Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Devices and Drugs Players by Revenue
3.1.1 Global Top Diabetes Devices and Drugs Players by Revenue (2020-2025)
3.1.2 Global Diabetes Devices and Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Diabetes Devices and Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Diabetes Devices and Drugs Revenue
3.4 Global Diabetes Devices and Drugs Market Concentration Ratio
3.4.1 Global Diabetes Devices and Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Devices and Drugs Revenue in 2024
3.5 Global Key Players of Diabetes Devices and Drugs Head office and Area Served
3.6 Global Key Players of Diabetes Devices and Drugs, Product and Application
3.7 Global Key Players of Diabetes Devices and Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Devices and Drugs Breakdown Data by Type
4.1 Global Diabetes Devices and Drugs Historic Market Size by Type (2020-2025)
4.2 Global Diabetes Devices and Drugs Forecasted Market Size by Type (2026-2031)
5 Diabetes Devices and Drugs Breakdown Data by Application
5.1 Global Diabetes Devices and Drugs Historic Market Size by Application (2020-2025)
5.2 Global Diabetes Devices and Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Diabetes Devices and Drugs Market Size (2020-2031)
6.2 North America Diabetes Devices and Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Diabetes Devices and Drugs Market Size by Country (2020-2025)
6.4 North America Diabetes Devices and Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diabetes Devices and Drugs Market Size (2020-2031)
7.2 Europe Diabetes Devices and Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Diabetes Devices and Drugs Market Size by Country (2020-2025)
7.4 Europe Diabetes Devices and Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Devices and Drugs Market Size (2020-2031)
8.2 Asia-Pacific Diabetes Devices and Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Diabetes Devices and Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Diabetes Devices and Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diabetes Devices and Drugs Market Size (2020-2031)
9.2 Latin America Diabetes Devices and Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Diabetes Devices and Drugs Market Size by Country (2020-2025)
9.4 Latin America Diabetes Devices and Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Devices and Drugs Market Size (2020-2031)
10.2 Middle East & Africa Diabetes Devices and Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Diabetes Devices and Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Diabetes Devices and Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Diabetes Devices and Drugs Introduction
11.1.4 Medtronic Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.1.5 Medtronic Recent Development
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Diabetes Devices and Drugs Introduction
11.2.4 BD Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.2.5 BD Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Diabetes Devices and Drugs Introduction
11.3.4 Johnson & Johnson Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Diabetes Devices and Drugs Introduction
11.4.4 Abbott Laboratories Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.4.5 Abbott Laboratories Recent Development
11.5 Novo Nordisk
11.5.1 Novo Nordisk Company Details
11.5.2 Novo Nordisk Business Overview
11.5.3 Novo Nordisk Diabetes Devices and Drugs Introduction
11.5.4 Novo Nordisk Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.5.5 Novo Nordisk Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Diabetes Devices and Drugs Introduction
11.6.4 Bristol-Myers Squibb Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 DexCom
11.7.1 DexCom Company Details
11.7.2 DexCom Business Overview
11.7.3 DexCom Diabetes Devices and Drugs Introduction
11.7.4 DexCom Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.7.5 DexCom Recent Development
11.8 Companion Medical
11.8.1 Companion Medical Company Details
11.8.2 Companion Medical Business Overview
11.8.3 Companion Medical Diabetes Devices and Drugs Introduction
11.8.4 Companion Medical Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.8.5 Companion Medical Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Details
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Diabetes Devices and Drugs Introduction
11.9.4 GlaxoSmithKline Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.9.5 GlaxoSmithKline Recent Development
11.10 Glenmark Pharmaceuticals
11.10.1 Glenmark Pharmaceuticals Company Details
11.10.2 Glenmark Pharmaceuticals Business Overview
11.10.3 Glenmark Pharmaceuticals Diabetes Devices and Drugs Introduction
11.10.4 Glenmark Pharmaceuticals Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.10.5 Glenmark Pharmaceuticals Recent Development
11.11 Novartis
11.11.1 Novartis Company Details
11.11.2 Novartis Business Overview
11.11.3 Novartis Diabetes Devices and Drugs Introduction
11.11.4 Novartis Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.11.5 Novartis Recent Development
11.12 Roche
11.12.1 Roche Company Details
11.12.2 Roche Business Overview
11.12.3 Roche Diabetes Devices and Drugs Introduction
11.12.4 Roche Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.12.5 Roche Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Diabetes Devices and Drugs Introduction
11.13.4 Sanofi Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.13.5 Sanofi Recent Development
11.14 MSD
11.14.1 MSD Company Details
11.14.2 MSD Business Overview
11.14.3 MSD Diabetes Devices and Drugs Introduction
11.14.4 MSD Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.14.5 MSD Recent Development
11.15 Astrazeneca
11.15.1 Astrazeneca Company Details
11.15.2 Astrazeneca Business Overview
11.15.3 Astrazeneca Diabetes Devices and Drugs Introduction
11.15.4 Astrazeneca Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.15.5 Astrazeneca Recent Development
11.16 Takeda
11.16.1 Takeda Company Details
11.16.2 Takeda Business Overview
11.16.3 Takeda Diabetes Devices and Drugs Introduction
11.16.4 Takeda Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.16.5 Takeda Recent Development
11.17 North China Pharmaceutical Group Corporation
11.17.1 North China Pharmaceutical Group Corporation Company Details
11.17.2 North China Pharmaceutical Group Corporation Business Overview
11.17.3 North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Introduction
11.17.4 North China Pharmaceutical Group Corporation Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.17.5 North China Pharmaceutical Group Corporation Recent Development
11.18 Huadong Medicine
11.18.1 Huadong Medicine Company Details
11.18.2 Huadong Medicine Business Overview
11.18.3 Huadong Medicine Diabetes Devices and Drugs Introduction
11.18.4 Huadong Medicine Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.18.5 Huadong Medicine Recent Development
11.19 Dongbao Pharmaceutical
11.19.1 Dongbao Pharmaceutical Company Details
11.19.2 Dongbao Pharmaceutical Business Overview
11.19.3 Dongbao Pharmaceutical Diabetes Devices and Drugs Introduction
11.19.4 Dongbao Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.19.5 Dongbao Pharmaceutical Recent Development
11.20 Hisun Pharmacy
11.20.1 Hisun Pharmacy Company Details
11.20.2 Hisun Pharmacy Business Overview
11.20.3 Hisun Pharmacy Diabetes Devices and Drugs Introduction
11.20.4 Hisun Pharmacy Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.20.5 Hisun Pharmacy Recent Development
11.21 KELUN
11.21.1 KELUN Company Details
11.21.2 KELUN Business Overview
11.21.3 KELUN Diabetes Devices and Drugs Introduction
11.21.4 KELUN Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.21.5 KELUN Recent Development
11.22 Ginwa
11.22.1 Ginwa Company Details
11.22.2 Ginwa Business Overview
11.22.3 Ginwa Diabetes Devices and Drugs Introduction
11.22.4 Ginwa Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.22.5 Ginwa Recent Development
11.23 Tianan Pharmaceutical
11.23.1 Tianan Pharmaceutical Company Details
11.23.2 Tianan Pharmaceutical Business Overview
11.23.3 Tianan Pharmaceutical Diabetes Devices and Drugs Introduction
11.23.4 Tianan Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2020-2025)
11.23.5 Tianan Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Diabetes Devices and Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Diabetes Devices
Table 3. Key Players of Diabetes Drugs
Table 4. Global Diabetes Devices and Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Diabetes Devices and Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Diabetes Devices and Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Diabetes Devices and Drugs Market Share by Region (2020-2025)
Table 8. Global Diabetes Devices and Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Diabetes Devices and Drugs Market Share by Region (2026-2031)
Table 10. Diabetes Devices and Drugs Market Trends
Table 11. Diabetes Devices and Drugs Market Drivers
Table 12. Diabetes Devices and Drugs Market Challenges
Table 13. Diabetes Devices and Drugs Market Restraints
Table 14. Global Diabetes Devices and Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Diabetes Devices and Drugs Market Share by Players (2020-2025)
Table 16. Global Top Diabetes Devices and Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Devices and Drugs as of 2024)
Table 17. Ranking of Global Top Diabetes Devices and Drugs Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Diabetes Devices and Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Diabetes Devices and Drugs, Headquarters and Area Served
Table 20. Global Key Players of Diabetes Devices and Drugs, Product and Application
Table 21. Global Key Players of Diabetes Devices and Drugs, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Diabetes Devices and Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Diabetes Devices and Drugs Revenue Market Share by Type (2020-2025)
Table 25. Global Diabetes Devices and Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Diabetes Devices and Drugs Revenue Market Share by Type (2026-2031)
Table 27. Global Diabetes Devices and Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Diabetes Devices and Drugs Revenue Market Share by Application (2020-2025)
Table 29. Global Diabetes Devices and Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Diabetes Devices and Drugs Revenue Market Share by Application (2026-2031)
Table 31. North America Diabetes Devices and Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Diabetes Devices and Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Diabetes Devices and Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Diabetes Devices and Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Diabetes Devices and Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Diabetes Devices and Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Diabetes Devices and Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Diabetes Devices and Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Diabetes Devices and Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Diabetes Devices and Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Diabetes Devices and Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Diabetes Devices and Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Diabetes Devices and Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Diabetes Devices and Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Diabetes Devices and Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 46. Medtronic Company Details
Table 47. Medtronic Business Overview
Table 48. Medtronic Diabetes Devices and Drugs Product
Table 49. Medtronic Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 50. Medtronic Recent Development
Table 51. BD Company Details
Table 52. BD Business Overview
Table 53. BD Diabetes Devices and Drugs Product
Table 54. BD Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 55. BD Recent Development
Table 56. Johnson & Johnson Company Details
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson Diabetes Devices and Drugs Product
Table 59. Johnson & Johnson Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. Abbott Laboratories Company Details
Table 62. Abbott Laboratories Business Overview
Table 63. Abbott Laboratories Diabetes Devices and Drugs Product
Table 64. Abbott Laboratories Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 65. Abbott Laboratories Recent Development
Table 66. Novo Nordisk Company Details
Table 67. Novo Nordisk Business Overview
Table 68. Novo Nordisk Diabetes Devices and Drugs Product
Table 69. Novo Nordisk Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 70. Novo Nordisk Recent Development
Table 71. Bristol-Myers Squibb Company Details
Table 72. Bristol-Myers Squibb Business Overview
Table 73. Bristol-Myers Squibb Diabetes Devices and Drugs Product
Table 74. Bristol-Myers Squibb Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 75. Bristol-Myers Squibb Recent Development
Table 76. DexCom Company Details
Table 77. DexCom Business Overview
Table 78. DexCom Diabetes Devices and Drugs Product
Table 79. DexCom Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 80. DexCom Recent Development
Table 81. Companion Medical Company Details
Table 82. Companion Medical Business Overview
Table 83. Companion Medical Diabetes Devices and Drugs Product
Table 84. Companion Medical Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 85. Companion Medical Recent Development
Table 86. GlaxoSmithKline Company Details
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Diabetes Devices and Drugs Product
Table 89. GlaxoSmithKline Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 90. GlaxoSmithKline Recent Development
Table 91. Glenmark Pharmaceuticals Company Details
Table 92. Glenmark Pharmaceuticals Business Overview
Table 93. Glenmark Pharmaceuticals Diabetes Devices and Drugs Product
Table 94. Glenmark Pharmaceuticals Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 95. Glenmark Pharmaceuticals Recent Development
Table 96. Novartis Company Details
Table 97. Novartis Business Overview
Table 98. Novartis Diabetes Devices and Drugs Product
Table 99. Novartis Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 100. Novartis Recent Development
Table 101. Roche Company Details
Table 102. Roche Business Overview
Table 103. Roche Diabetes Devices and Drugs Product
Table 104. Roche Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 105. Roche Recent Development
Table 106. Sanofi Company Details
Table 107. Sanofi Business Overview
Table 108. Sanofi Diabetes Devices and Drugs Product
Table 109. Sanofi Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 110. Sanofi Recent Development
Table 111. MSD Company Details
Table 112. MSD Business Overview
Table 113. MSD Diabetes Devices and Drugs Product
Table 114. MSD Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 115. MSD Recent Development
Table 116. Astrazeneca Company Details
Table 117. Astrazeneca Business Overview
Table 118. Astrazeneca Diabetes Devices and Drugs Product
Table 119. Astrazeneca Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 120. Astrazeneca Recent Development
Table 121. Takeda Company Details
Table 122. Takeda Business Overview
Table 123. Takeda Diabetes Devices and Drugs Product
Table 124. Takeda Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 125. Takeda Recent Development
Table 126. North China Pharmaceutical Group Corporation Company Details
Table 127. North China Pharmaceutical Group Corporation Business Overview
Table 128. North China Pharmaceutical Group Corporation Diabetes Devices and Drugs Product
Table 129. North China Pharmaceutical Group Corporation Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 130. North China Pharmaceutical Group Corporation Recent Development
Table 131. Huadong Medicine Company Details
Table 132. Huadong Medicine Business Overview
Table 133. Huadong Medicine Diabetes Devices and Drugs Product
Table 134. Huadong Medicine Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 135. Huadong Medicine Recent Development
Table 136. Dongbao Pharmaceutical Company Details
Table 137. Dongbao Pharmaceutical Business Overview
Table 138. Dongbao Pharmaceutical Diabetes Devices and Drugs Product
Table 139. Dongbao Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 140. Dongbao Pharmaceutical Recent Development
Table 141. Hisun Pharmacy Company Details
Table 142. Hisun Pharmacy Business Overview
Table 143. Hisun Pharmacy Diabetes Devices and Drugs Product
Table 144. Hisun Pharmacy Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 145. Hisun Pharmacy Recent Development
Table 146. KELUN Company Details
Table 147. KELUN Business Overview
Table 148. KELUN Diabetes Devices and Drugs Product
Table 149. KELUN Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 150. KELUN Recent Development
Table 151. Ginwa Company Details
Table 152. Ginwa Business Overview
Table 153. Ginwa Diabetes Devices and Drugs Product
Table 154. Ginwa Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 155. Ginwa Recent Development
Table 156. Tianan Pharmaceutical Company Details
Table 157. Tianan Pharmaceutical Business Overview
Table 158. Tianan Pharmaceutical Diabetes Devices and Drugs Product
Table 159. Tianan Pharmaceutical Revenue in Diabetes Devices and Drugs Business (2020-2025) & (US$ Million)
Table 160. Tianan Pharmaceutical Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
Table 164. Authors List of This Report


List of Figures
Figure 1. Diabetes Devices and Drugs Picture
Figure 2. Global Diabetes Devices and Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Diabetes Devices and Drugs Market Share by Type: 2024 VS 2031
Figure 4. Diabetes Devices Features
Figure 5. Diabetes Drugs Features
Figure 6. Global Diabetes Devices and Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Diabetes Devices and Drugs Market Share by Application: 2024 VS 2031
Figure 8. Diagnostic/Clinics Case Studies
Figure 9. ICUs Case Studies
Figure 10. Home Healthcare Case Studies
Figure 11. Diabetes Devices and Drugs Report Years Considered
Figure 12. Global Diabetes Devices and Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Diabetes Devices and Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Diabetes Devices and Drugs Market Share by Region: 2024 VS 2031
Figure 15. Global Diabetes Devices and Drugs Market Share by Players in 2024
Figure 16. Global Top Diabetes Devices and Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Devices and Drugs as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Diabetes Devices and Drugs Revenue in 2024
Figure 18. North America Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Diabetes Devices and Drugs Market Share by Country (2020-2031)
Figure 20. United States Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Diabetes Devices and Drugs Market Share by Country (2020-2031)
Figure 24. Germany Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Diabetes Devices and Drugs Market Share by Region (2020-2031)
Figure 32. China Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Diabetes Devices and Drugs Market Share by Country (2020-2031)
Figure 40. Mexico Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Diabetes Devices and Drugs Market Share by Country (2020-2031)
Figure 44. Turkey Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Diabetes Devices and Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Medtronic Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 48. BD Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 49. Johnson & Johnson Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 50. Abbott Laboratories Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 51. Novo Nordisk Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 53. DexCom Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 54. Companion Medical Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 55. GlaxoSmithKline Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 56. Glenmark Pharmaceuticals Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 57. Novartis Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 58. Roche Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 59. Sanofi Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 60. MSD Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 61. Astrazeneca Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 62. Takeda Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 63. North China Pharmaceutical Group Corporation Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 64. Huadong Medicine Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 65. Dongbao Pharmaceutical Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 66. Hisun Pharmacy Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 67. KELUN Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 68. Ginwa Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 69. Tianan Pharmaceutical Revenue Growth Rate in Diabetes Devices and Drugs Business (2020-2025)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies